logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

FairJourney Biologics acquires Charles River facility

Mar 04, 2025•10 months ago

Acquiring Company

FairJourney Biologics

Acquired Company

Charles River

PortoWilmingtonBiotechnologyBiotechnology

Description

FairJourney Biologics S.A. has completed the acquisition of the South San Francisco site from Charles River Laboratories. This strategic acquisition enhances FairJourney’s capabilities in antibody discovery and engineering. The integration of Charles River's proprietary technologies will strengthen FairJourney’s portfolio, enabling them to offer more diverse solutions. The deal positions FairJourney to expand its presence in a key biotechnology hub.

Company Information

Company

FairJourney Biologics

Location

Porto, Porto, Portugal

About

At FairJourney Biologics, we specialize in cutting-edge antibody discovery and development, offering end-to-end solutions that fast-track your research. With over a decade of expertise, our innovative technologies and seasoned team have successfully advanced 14 antibodies to clinical stages. Our adaptable partnership model empowers projects of any scale, fostering collaboration and breakthrough innovation. Whether you're in early-stage research or development, we deliver tailored, high-quality antibodies designed to meet your specific needs.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed